Sherrington Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2002.
2002 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Sherrington Pharmaceuticals Private Limited

Sherrington Pharmaceuticals Private Limited, a active private limited company, was established on 09 October 2002 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TG2002PTC039741. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.20 M.

It upholds a compliant status. Its leadership includes Manogna Yeluri (Managing Director), Yeluri Hari Prasad (Director). Past directors included Manogna Yeluri, Yeluri Hari Prasad, Pasupathi Nadh Yeluri. It holds ₹76.09 Cr open charges and ₹1.62 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Avm Towers,No.4 2Nd Floor,Opp Kphb Col Near Shivaparvathi Theater, Kukatpally, Hyderabad, Telangana, 500072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231TG2002PTC039741

  • Registration Number

    039741

  • Incorporation Date

    09 October 2002

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.20 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 23 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 76.09 Cr
  • Satisfied Charges ₹ 1.62 Cr
  • Revenue Growth **** 18.29%
  • Profit Growth **** 25.31%
  • Ebitda **** -12.58%
  • Net Worth 18.29%
  • Total Assets **** 26.30%
Company report

Sherrington Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sherrington Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sherrington Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Manogna Yeluri Managing Director 19 Aug 2019 Current
Yeluri Hari Prasad Director 09 Oct 2002 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 11 Aug 2022 Past
Pramod Abcsdd Managing Director 11 Aug 2022 Past
Pramod Abcsdd Director 10 Oct 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sherrington Pharmaceuticals.

Sherrington Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.29% increase. The company also saw a substantial improvement in profitability, with a 25.31% increase in profit. The company's net worth Soared by an impressive increase of 18.29%.

Sherrington Pharmaceuticals revenue growth over time
Sherrington Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 18.29%
*******
*******
*******
*******
Revenue from Operations
*******
 18.64%
*******
*******
*******
*******
Total Assets
*******
 26.30%
*******
*******
*******
*******
Profit or Loss
*******
 25.31%
*******
*******
*******
*******
Net Worth
*******
 18.29%
*******
*******
*******
*******
EBITDA
*******
 -12.58%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sherrington Pharmaceuticals?

Unlock access to Sherrington Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹760,879,444.00

Satisfied Charges

₹16,240,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 44.80 Cr
  • Others : 20.74 Cr
  • Ing Vysya Bank Limited : 10.55 Cr
Latest Charge Details
Date Lender Amount Status
30 Jun 2022 Hdfc Bank Limited ₹2.11 M Open
03 Mar 2021 Hdfc Bank Limited ₹44.59 Cr Open
21 Sep 2017 Others ₹20.74 Cr Open
23 Aug 2011 Ing Vysya Bank Limited ₹8.55 Cr Open
28 Feb 2011 Ing Vysya Bank Limited ₹2.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Sherrington Pharmaceuticals?

Unlock and access historical data on people associated with Sherrington Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sherrington Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sherrington Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sherrington Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 445.87 M registered on 03 Mar 2021 with Charge ID 100424143 was modified on 19 Feb 2025. was documented.

  • Annual General Meeting

    Progress on Sherrington Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Sherrington Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 2.11 M with Charge ID 100593146 was registered on 30 Jun 2022. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 445.87 M with Charge ID 100424143 was registered on 03 Mar 2021. was recorded as a recent event.

  • Director Appointment

    Manogna Yeluri was appointed as a Managing Director was appointed as a Managing Director on 19 Aug 2019 & has been associated with this company since 6 years 6 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sherrington Pharmaceuticals Private Limited?

The CIN of Sherrington Pharmaceuticals Private Limited is U24231TG2002PTC039741.

Where is Sherrington Pharmaceuticals Private Limited headquartered?

Sherrington Pharmaceuticals Private Limited is headquartered at Avm Towers,No.4 2Nd Floor,Opp Kphb Col Near Shivaparvathi Theater, Kukatpally, Hyderabad, Telangana, 500072.

When was Sherrington Pharmaceuticals Private Limited incorporated?

Sherrington Pharmaceuticals Private Limited was incorporated on 09 October 2002.

Who are the current directors of Sherrington Pharmaceuticals Private Limited?

The current directors of Sherrington Pharmaceuticals Private Limited are

What is the primary industry of Sherrington Pharmaceuticals Private Limited?

The primary industry of Sherrington Pharmaceuticals Private Limited is Manufacturing.

Is Sherrington Pharmaceuticals Private Limited a listed company?

Sherrington Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Sherrington Pharmaceuticals Private Limited?

The authorized capital of Sherrington Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.20 M.

What is the compliance status of Sherrington Pharmaceuticals Private Limited?

The compliance status of Sherrington Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available